ISOSORBIDE Safety Questions, ISOSORBIDE Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about ISOSORBIDE. Our extensive database of ISOSORBIDE adverse events and ISOSORBIDE warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about ISOSORBIDE

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




ISOSORBIDE Safety Reports

Total ISOSORBIDE reports: 48.
ISOSORBIDE FDA safety alerts: No.
Reported deaths: 6    Reported hospitalizations: 28.
Take ISOSORBIDE Side Effects Survey or Share Your ISOSORBIDE Story. ISOSORBIDE Usage.

Physician from JAPAN reported ISOSORBIDE problem on Dec 25, 2006. Female patient, weighting 108.0 lb, was diagnosed with myocardial infarction, gastritis, hyperlipidaemia, hypertension, thrombosis prophylaxis and was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: anaemia, blood alkaline phosphatase increased, post procedural haematoma, transaminases increased. ISOSORBIDE dosage: unknown. During the same period patient was treated with ASPIRIN, MUCOSTA, LIPITOR, BLOPRESS, PLAVIX. Patient recovered.

ISOSORBIDE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 21, 2006. Male patient, 77 years of age, was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: hypersensitivity, lip swelling. ISOSORBIDE dosage: 10 MG; BID; PO. During the same period patient was treated with ATENOLOL, CLOPIDOGREL, RAMIPRIL, SIMVASTATIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ISOSORBIDE problem on Feb 06, 2007. Female patient, 47 years of age, weighting 206.0 lb, was diagnosed with angina unstable and was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: headache. ISOSORBIDE dosage: unknown. Patient recovered.

ISOSORBIDE problem was reported by a Physician from CHINA on Feb 14, 2007. Male patient, 70 years of age, was diagnosed with lung adenocarcinoma, metastases to central nervous system and was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: abdominal distension, constipation, gastrointestinal pain, x-ray gastrointestinal tract abnormal. ISOSORBIDE dosage: unknown. During the same period patient was treated with IRESSA, CEFTAZIDIME. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from CANADA reported ISOSORBIDE problem on June 02, 2006. Female patient, 50 years of age, was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: back pain, chest pain, dyspnoea, gait disturbance, hyperhidrosis. ISOSORBIDE dosage: 60MG, 1 IN 1 D, ORAL. During the same period patient was treated with ATENOLOL, CARVEDILOL, ACETYLSALICYLIC ACID SRT. Patient recovered.

ISOSORBIDE problem was reported by a Physician from CHINA on Feb 22, 2007. Male patient, 70 years of age, was diagnosed with lung adenocarcinoma, metastases to central nervous system and was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: intestinal obstruction. ISOSORBIDE dosage: unknown. During the same period patient was treated with IRESSA, CEFTAZIDIME. Patient was hospitalized. Patient recovered.

Physician from CHINA reported ISOSORBIDE problem on Mar 09, 2007. Male patient, 70 years of age, was diagnosed with cardiac disorder, lung adenocarcinoma, metastasis, lung infection and was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: intestinal obstruction. ISOSORBIDE dosage: unknown. During the same period patient was treated with IRESSA, CEFTAZIDIME. Patient was hospitalized. Patient recovered.

ISOSORBIDE problem was reported by a Pharmacist from UNITED STATES on Mar 28, 2007. Male patient, 63 years of age, weighting 337.1 lb, was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: urticaria. ISOSORBIDE dosage: unknown. During the same period patient was treated with FUROSEMIDE, LANOXIN, TRAMADOL, CYCLOBENZAPRINE, SPIRONOLACTONE, COUMADIN, GABAPENTIN, ISOSORBIDE MONONITRATE. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported ISOSORBIDE problem on May 09, 2007. Male patient, 55 years of age, was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: fall, glasgow coma scale abnormal, no therapeutic response. ISOSORBIDE dosage: unknown. During the same period patient was treated with OLANZAPINE, ASPIRIN. Patient was hospitalized. Patient recovered.

ISOSORBIDE problem was reported by a Physician from UNITED STATES on May 29, 2007. Female patient, weighting 122.1 lb, was diagnosed with squamous cell carcinoma and was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: cholecystitis. ISOSORBIDE dosage: unknown. During the same period patient was treated with LISINOPRIL, DIGITEK, FOSAMAX, HYDROCHLOROTHIAZIDE, HYDROCODONE BITARTRATE, LEVOTHYROXINE, LIPITOR. Patient was hospitalized. Patient recovered.

Physician from UNITED KINGDOM reported ISOSORBIDE problem on June 01, 2007. Male patient, 55 years of age, was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, fall, muscle disorder, overdose. ISOSORBIDE dosage: unknown. During the same period patient was treated with OLANZAPINE, ASPIRIN. Patient was hospitalized. Patient recovered.

ISOSORBIDE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 01, 2007. Male patient, 55 years of age, was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, depressed level of consciousness, overdose. ISOSORBIDE dosage: unknown. During the same period patient was treated with ASPIRIN, OLANZAPINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ISOSORBIDE problem on June 26, 2006. Male patient was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: obstruction, pain, scar, stent placement. ISOSORBIDE dosage: unknown. Patient recovered.

ISOSORBIDE problem was reported by a Consumer or non-health professional from UNITED STATES on June 16, 2006. Male patient, 75 years of age, weighting 120.0 lb, was diagnosed with angina pectoris and was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: chest pain, intervertebral disc protrusion, sciatica. ISOSORBIDE dosage: 60MG, 1 IN 1 D, ORAL. During the same period patient was treated with ATORVASTATIN CALCIUM, VALSARTAN, AMLODIPINE BESYLATE, CLOPIDOGREL BISULPHATE, PREGABALIN, MORPHINE, HYDROCODONE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported ISOSORBIDE problem on June 30, 2006. Female patient was diagnosed with angina pectoris, fluid retention and was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood urea increased, hypovolaemia. ISOSORBIDE dosage: 60 MG QD ORAL. During the same period patient was treated with FUROSEMIDE, AMITRIPTYLINE, BETAMETHASONE, CHLORDIAZEPOXIDE, EZETROL, NICORANDIL, RANITIDINE, XALATAN. Patient was hospitalized. Patient recovered.

ISOSORBIDE problem was reported by a Physician from KOREA, REPUBLIC OF on June 16, 2006. Male patient, weighting 134.5 lb, was diagnosed with angina pectoris, hyperlipidaemia, hypertension, thrombosis prophylaxis and was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: gastric cancer, haematochezia. ISOSORBIDE dosage: unknown. During the same period patient was treated with ATORVASTATIN CALCIUM, BETAXOLOL, VALSARTAN, NIFEDIPINE, ASPIRIN, PLAVIX. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from ITALY reported ISOSORBIDE problem on Aug 01, 2006. Female patient, 78 years of age, was diagnosed with chest pain and was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, cardiac failure congestive, heart rate decreased, ventricular extrasystoles. ISOSORBIDE dosage: 5 MG. Patient was hospitalized. Patient recovered.

ISOSORBIDE problem was reported by a Consumer or non-health professional from GERMANY on June 01, 2006. Male patient, 42 years of age, was diagnosed with anal fissure and was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: anorectal disorder, blood pressure increased, dizziness, headache, heart rate increased, venous thrombosis, vomiting. ISOSORBIDE dosage: unknown. During the same period patient was treated with BISOPROLOL FUMARATE, DELIX PLUS. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported ISOSORBIDE problem on Aug 11, 2006. Female patient, 85 years of age, was diagnosed with angina pectoris, fluid retention and was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood urea increased, hypovolaemia. ISOSORBIDE dosage: 60 MG QD ORAL. During the same period patient was treated with FUROSEMIDE NO DOSEM, AMITRIPTYLINE, BETAMETHASONE, CHLORDIAZEPOXIDE, EZETROL, NICORANDIL, RANITIDINE, XALATAN. Patient was hospitalized. Patient recovered.

ISOSORBIDE problem was reported by a Health Professional from DENMARK on Aug 04, 2006. Female patient was diagnosed with angina pectoris and was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood urea increased, hypovolaemia. ISOSORBIDE dosage: 60 MG;QD;PO. During the same period patient was treated with AMITRIPTYLINE, BETAMETHASONE, CHLORDIAZEPOXIDE, EZETIMIBE, NICORANDIL, RANITIDINE, XALATAN, FUROSEMIDE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ISOSORBIDE problem on Aug 11, 2006. Male patient was treated with ISOSORBIDE. ISOSORBIDE dosage: unknown. Patient died on 07/24/2006.

ISOSORBIDE problem was reported by a Consumer or non-health professional from DENMARK on Aug 28, 2006. Male patient, 58 years of age, was diagnosed with angina pectoris and was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: coronary artery occlusion, myocardial infarction, syncope, ventricular fibrillation. ISOSORBIDE dosage: 10 MG;QD;PO. During the same period patient was treated with TADALAFIL, ATROVENT AEROSOL, FORADIL AEROSOL. Patient died.

Physician from CHINA reported ISOSORBIDE problem on Dec 14, 2005. Female patient, weighting 176.4 lb, was diagnosed with coronary artery disease, percutaneous coronary intervention, coronary angioplasty and was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: confusional state, hallucination, restlessness, speech disorder. ISOSORBIDE dosage: 60 MG. During the same period patient was treated with ASPIRIN, PLAVIX. Patient recovered.

ISOSORBIDE problem was reported by a Physician from UNITED STATES on Oct 05, 2006. Male patient, 82 years of age, weighting 175.0 lb, was diagnosed with coronary artery disease, myocardial infarction and was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: rash. ISOSORBIDE dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ISOSORBIDE problem on Oct 10, 2006. Female patient, 65 years of age, was diagnosed with chest pain and was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, chest pain, dysphagia, myocardial infarction, rash. ISOSORBIDE dosage: 120MG, 1 IN 1 D, ORAL. During the same period patient was treated with BISOPROLOL FUMARATE, BENAZEPRIL HYDROCHLORIDE, DULOXETINE, DIGOXIN, FUROSEMIDE, LEVOTHYROXINE, ESOMEPRAZOLE MAGNESIUM, HYOSCYAMINE. Patient was hospitalized. Patient recovered.

ISOSORBIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 17, 2006. Female patient was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive. ISOSORBIDE dosage: 30 MG ORAL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ISOSORBIDE problem on Oct 31, 2006. Female patient, 65 years of age, weighting 180.0 lb, was diagnosed with chest pain and was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: cardiac disorder, cardiac failure congestive, dyspnoea, myocardial infarction. ISOSORBIDE dosage: 120 MG, 1 IN 1 D; ORAL. During the same period patient was treated with BISOPROLOL FUMARATE, DULOXETINE, DIGOXIN, FUROSEMIDE, LEVOTHYROXINE, ESOMEPRAZOLE MAGNESIUM, HYOSCYAMINE, ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient recovered.

ISOSORBIDE problem was reported by a Consumer or non-health professional from FRANCE on Nov 10, 2006. Male patient, 66 years of age, was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: asthenia, blood creatine increased, bradyphrenia, cardiomyopathy, condition aggravated, cytolytic hepatitis, disseminated intravascular coagulation, fall, haematoma. ISOSORBIDE dosage: unknown. During the same period patient was treated with NOCTRAN, XANAX, PERINDOPRIL ERBUMINE, NICARDIPINE HYDROCHLORIDE, PROZAC. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported ISOSORBIDE problem on Oct 24, 2006. Female patient, 57 years of age, was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: completed suicide, poisoning. ISOSORBIDE dosage: unknown. During the same period patient was treated with DILTIAZEM, DOXAZOSIN MESYLATE. Patient died.

ISOSORBIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 27, 2006. Female patient, 83 years of age, was treated with ISOSORBIDE. ISOSORBIDE dosage: unknown. During the same period patient was treated with PROTONIX, BETAPACE, LIPITOR, DITROPAN, NORVASC. Patient died.

Consumer or non-health professional from SWEDEN reported ISOSORBIDE problem on Aug 01, 2006. Male patient, 91 years of age, was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: transient ischaemic attack, vertigo. ISOSORBIDE dosage: unknown. During the same period patient was treated with OMEPRAZOLE, ZOPICLONE, LACTULOSE, GLYCERYL TRINITRATE, GLYCERYL TRINITRATE, SPASMOFEN, HALOPERIDOL, FERROUS FUMARATE. Patient was hospitalized. Patient recovered.

ISOSORBIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 06, 2006. Male patient, 59 years of age, weighting 260.4 lb, was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: headache. ISOSORBIDE dosage: unknown. Patient recovered.

Consumer or non-health professional from AUSTRIA reported ISOSORBIDE problem on Nov 27, 2006. Male patient, 61 years of age, was diagnosed with erectile dysfunction and was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: aortic dissection, atrial fibrillation, blood lactate dehydrogenase increased, blood pressure diastolic decreased, blood pressure systolic increased, diarrhoea, international normalised ratio increased, intestinal ischaemia, ventricular hypertrophy. ISOSORBIDE dosage: unknown. During the same period patient was treated with SILDENAFIL CITRATE, DIGITOXIN, ALLOPURINOL, RANITIDINE, FLAVONOID, DIOSMIN, PHENPROCOUMON. Patient died.

ISOSORBIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 27, 2006. Male patient, 75 years of age, weighting 120.0 lb, was diagnosed with angina pectoris and was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: chest pain, intervertebral disc protrusion, sciatica. ISOSORBIDE dosage: 60 MG, 1 IN 1 D, ORAL. During the same period patient was treated with ATORVASTATIN CALCIUM, VALSARTAN, AMLODIPINE BESYLATE, CLOPIDOGREL BISULPHATE, PREGABALIN, MORPHINE, HYDROCODONE BITARTRATE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ISOSORBIDE problem on Dec 11, 2006. Female patient, 82 years of age, was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: completed suicide. ISOSORBIDE dosage: unknown. During the same period patient was treated with DILTIAZEM, METOPROLOL TARTRATE, ADDITIONAL SUBSTANCES. Patient died.

ISOSORBIDE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 04, 2007. Male patient, 55 years of age, was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, depressed level of consciousness, fall, glasgow coma scale abnormal, intentional overdose, no therapeutic response. ISOSORBIDE dosage: unknown. During the same period patient was treated with ASPIRIN. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported ISOSORBIDE problem on July 20, 2007. Male patient, weighting 210.0 lb, was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: angina pectoris. ISOSORBIDE dosage: unknown. Patient recovered.

ISOSORBIDE problem was reported by a Health Professional from UNITED KINGDOM on July 16, 2007. Female patient, 89 years of age, was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: fall, microcytic anaemia, mobility decreased, orthostatic hypotension. ISOSORBIDE dosage: unknown. During the same period patient was treated with TOLTERODINE TARTRATE, LEVOTHYROXINE, METFORMIN, CITALOPRAM HYDROBROMIDE, ALLOPURINOL, ASPIRIN, GABAPENTIN. Patient was hospitalized. Patient recovered.

Health Professional from UNITED KINGDOM reported ISOSORBIDE problem on July 17, 2007. Female patient, 89 years of age, was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: fall, microcytic anaemia, mobility decreased, orthostatic hypotension. ISOSORBIDE dosage: unknown. During the same period patient was treated with TOLTERODINE TARTRATE, ALLOPURINOL, ASPIRIN, CITALOPRAM HYDROBROMIDE, GABAPENTIN, LEVOTHYROXINE, METFORMIN. Patient was hospitalized. Patient recovered.

ISOSORBIDE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 17, 2007. Female patient, 89 years of age, was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: fall, microcytic anaemia, orthostatic hypotension. ISOSORBIDE dosage: unknown. During the same period patient was treated with TOLTERODINE TARTRATE, ALLOPURINOL, ASPIRIN, CITALOPRAM HYDROBROMIDE, GABAPENTIN, LEVOTHYROXINE, METFORMIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from GERMANY reported ISOSORBIDE problem on July 16, 2007. Female patient, 78 years of age, was diagnosed with suicide attempt and was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: cardiovascular insufficiency, intestinal ischaemia, overdose, vasodilatation. ISOSORBIDE dosage: unknown. During the same period patient was treated with AMLODIPINE, BENAZEPRIL, MIRTAZAPINE. Patient was hospitalized. Patient recovered.

ISOSORBIDE problem was reported by a Consumer or non-health professional from GERMANY on July 16, 2007. Female patient, 78 years of age, was diagnosed with suicide attempt and was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: cardiovascular insufficiency, intestinal ischaemia, no therapeutic response, shock, suicidal ideation, vasodilatation. ISOSORBIDE dosage: unknown. During the same period patient was treated with AMLODIPINE, BENAZEPRIL, MIRTAZAPINE. Patient was hospitalized. Patient recovered.

Health Professional from UNITED KINGDOM reported ISOSORBIDE problem on Sept 12, 2007. Female patient, 67 years of age, was diagnosed with cardiovascular disorder, angioplasty and was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: dialysis, diarrhoea, electrocardiogram qrs complex prolonged, electrocardiogram t wave amplitude decreased, renal failure acute, shock, unresponsive to stimuli. ISOSORBIDE dosage: 10 MG;QD;PO. During the same period patient was treated with BISOPROLOL FUMARATE, BUMETANIDE, ENALAPRIL MALEATE. Patient was hospitalized. Patient recovered.

ISOSORBIDE problem was reported by a Pharmacist from UNITED KINGDOM on Sept 11, 2007. Female patient was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, dysphagia. ISOSORBIDE dosage: 20 MG; BID; PO. Patient recovered.

Health Professional from UNITED KINGDOM reported ISOSORBIDE problem on Sept 13, 2007. Female patient, 67 years of age, was diagnosed with cardiovascular disorder, angioplasty and was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: blood pressure systolic decreased, bradycardia, dialysis, diarrhoea, electrocardiogram qrs complex prolonged, electrocardiogram t wave abnormal, loss of consciousness, renal failure acute, unresponsive to stimuli. ISOSORBIDE dosage: 10 MG; QD; PO. During the same period patient was treated with BISOPROLOL FUMARATE, BUMETANIDE, ENALAPRIL MALEATE. Patient was hospitalized. Patient recovered.

ISOSORBIDE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 11, 2007. Female patient was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, dysphagia. ISOSORBIDE dosage: 20 MG; BID; PO. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported ISOSORBIDE problem on Sept 11, 2007. Female patient was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, condition aggravated, dysphagia. ISOSORBIDE dosage: 40 MG (20 MG, 2IN 1 D). Patient recovered.

ISOSORBIDE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 29, 2005. Female patient, 67 years of age, was diagnosed with cardiovascular disorder, angiopathy and was treated with ISOSORBIDE. After drug was administered, patient experienced the following problems/side effects: blood potassium increased, blood pressure diastolic decreased, bradycardia, diarrhoea, electrocardiogram qrs complex prolonged, renal failure acute, unresponsive to stimuli. ISOSORBIDE dosage: 10 MG. During the same period patient was treated with BISOPROLOL FUMARATE, BUMETANIDE, ENALAPRIL MALEATE, ENALAPRIL MALEATE. Patient was hospitalized. Patient recovered.

Ask Our Patient Community about ISOSORBIDE

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant

Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
PhenerganThis drug has as active FDA Safety Alert (promethazine)
Pimecrolimus

PioglitazoneThis drug has as active FDA Safety Alert
Placidyl (ethchlorvynol)
Plan B (levonorgestrel)
Pletal (cilostazol)
Poractant alfa
Posaconazole
Pramlintide Acetate
Precedex (dexmedetomidine)
PregabalinThis drug has as active FDA Safety Alert
Prezista (darunavir)
Prialt (ziconotide)
Priftin (rifapentine)
PrinivilThis drug has as active FDA Safety Alert (lisinopril)
ProcritThis drug has as active FDA Safety Alert (epoetin alfa)
ProHanceThis drug has as active FDA Safety Alert (gadoteridol)
PromethazineThis drug has as active FDA Safety Alert
PropofolThis drug has as active FDA Safety Alert
Prosom (estazolam)
Protonix (pantoprazole)
Protopic (tacrolimus)
Provigil (modafinil)
ProzacThis drug has as active FDA Safety Alert (fluoxetine)
Prussian blue


back to top

Q
Quazepam
Quetiapine

QuinaprilThis drug has as active FDA Safety Alert
Quinupristin

R
Rabeprazole
Radiogardase
(prussian blue)
Ramelteon
RamiprilThis drug has as active FDA Safety Alert
Ranexa (ranolazine)
Ranibizumab
Ranolazine
Rapamune (sirolimus)
Raptiva (efalizumab)
Rasagiline
RazadyneThis drug has as active FDA Safety Alert (galantamine)
Rebetol (ribavirin)
ReclastThis drug has as active FDA Safety Alert (zoledronic acid)
Refludan (lepirudin recombinant)
Relenza (zanamivir)
RelpaxThis drug has as active FDA Safety Alert (eletriptan)
RemeronThis drug has as active FDA Safety Alert (mirtazapine)
Renagel (sevelamer)
Rescula (unoprostone isopropyl)
Restoril (temazepam)
Revatio (sildenafil)
Revlimid (lenalidomide)
Reyataz (atazanavir sulfate)
Ribasphere (ribavarin ribasphere)
Ribavarin ribasphere
Rifapentine
Rifaximin
RisedronateThis drug has as active FDA Safety Alert
Risperdal (risperidone)
Risperidone
Ritalin (methylphenidate)
Ritonavir
RituxanThis drug has as active FDA Safety Alert
RituximabThis drug has as active FDA Safety Alert
Rivastigmine tartrate
RizatriptanThis drug has as active FDA Safety Alert
RocephinThis drug has as active FDA Safety Alert (ceftriaxone)
Rofecoxib
RosuvastatinThis drug has as active FDA Safety Alert
Rozerem (ra